Arena Pharmaceuticals Soared On Rumor - NASDAQ:ARNA, GPRC, CLNT, SATC, AEZS

Las Vegas, NV -- (SBWIRE) -- 08/15/2012 -- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares climbed 14.09% and closed at $8.26 in the previous trading session on renewed speculation that the company could be an acquisition target after getting FDA’s approval for its new diet drug lorcaserin, also known as Belviq in June.

In other news, The company reported a second-quarter net loss of $22.1 million or $0.12 per share, narrower than $22.9 million or $0.16 per share in the year-ago quarter. Total revenue rose to $21.98 million from $3.26 million in the comparable quarter last year. Analysts expected the company report a loss of $0.07 per share on revenue of $10.04 million for the second quarter.

Can ARNA Continue To Move higher? Is there Any Buyout Chance? Find Out Here http://www.phd-trading.com/lp6/index.php?code=ARNA

PhD Trading.com is a powerful trading system, used to generate millions of dollars worldwide every day. The best systems in the world are those that can be duplicated! Now anyone can successfully and profitably learn to trade stocks and options as a REAL business from home or anywhere you please.

Guanwei Recycling Corp. (NASDAQ:GPRC) shares jumped 38.10% and closed at $0.870 in the last trading session after the company’s second quarter revenues increased 18.6% to $18,694,938, as compared with revenues of $15,757,662 in the same quarter last year. The resulting lower profit margins contributed to an 8.41% year over year decline in net income to $3,163,030, or $0.15 per share, compared with $3,453,360, or $0.17 per share, in the 2011 second quarter.

How Far Can GPRC Go? Find Out here http://www.phd-trading.com/lp6/index.php?code=GPRC

Cleantech Solutions International Inc (NASDAQ:CLNT) shares soared 37.40% and closed at $3.38 in the previous trading session after the company reported second quarter revenue that increased 1.8% to $12.8 million, as compared to $12.6 million for the same period of 2011. Net income for the second quarter of 2012 was $1.1 million, or $0.40 diluted earnings per share, as compared to $1.2 million, or $0.47 diluted earnings per share, in the year ago period.

How To Trade CLNT Now, Get Special Report http://www.phd-trading.com/lp6/index.php?code=CLNT

SatCon Technology Corporation (NASDAQ:SATC) shares climbed 19.51% and closed at $1.47 in yesterday’s session. Analysts at Stifel Nicolaus lowered their price target on shares of SatCon Tech to $4.00 last week.

Can SATC Rebound Now? Find Out Here http://www.phd-trading.com/lp6/index.php?code=SATC

Additionally, the company expects third quarter revenue to be between $25-$30 million. Analysts are expecting the Company to report revenue of $36 million for third quarter of 2012.

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares jumped 19.44% and closed at $0.510 in the last trading session after the company posted second-quarter net income of $4.5 million or $0.04 per share, as compared to a loss of $10.6 million or $0.12 per share in the same period last year. Revenues for the quarter increased to $7.5 million from $6.5 million in the same quarter last year. The company reported a second-quarter profit, helped primarily by a change in fair value of warrant liability, as well as gains from foreign currency translations.

How To Trade AEZS Now, Get Special Report http://www.phd-trading.com/lp6/index.php?code=AEZS

Disclaimer:

The assembled information disseminated by phd-trading.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. phd-trading.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.

Contact:
phd-trading.com
staff@phd-trading.com